WORLAND STEPHEN T

CIK 00012833074 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001283307

Recent Transactions

44 trades

Award
eFFECTOR Therapeutics, Inc.
Common Stock
2024-05-15$1.68/sh+1,806→ 12,494 total
Award
eFFECTOR Therapeutics, Inc.
Stock Option (Right to Buy)
2024-02-19+80,000→ 80,000 total
Award
eFFECTOR Therapeutics, Inc.
Common Stock
2023-11-15$0.50/sh+5,979→ 267,204 total
Exercise/Conversion
eFFECTOR Therapeutics, Inc.
Common Stock
2023-08-11$0.52/sh+33,799→ 261,225 total
Exercise/Conversion
eFFECTOR Therapeutics, Inc.
Stock Option (Right to Buy)
2023-08-11−33,799→ 0 total
Award
eFFECTOR Therapeutics, Inc.
Common Stock
2023-05-15$0.46/sh+6,401→ 227,426 total
Award
Tracon Pharmaceuticals, Inc.
Director Stock Option (Right to Buy)
2023-04-19+18,000→ 18,000 total
Award
eFFECTOR Therapeutics, Inc.
Stock Option (Right to Buy)
2023-01-17+1,000,000→ 1,000,000 total
Award
eFFECTOR Therapeutics, Inc.
Common Stock
2022-11-15$0.47/sh+6,047→ 221,025 total
Award
eFFECTOR Therapeutics, Inc.
Stock Option (Right to Buy)
2022-06-20+520,674→ 520,674 total
Award
Tracon Pharmaceuticals, Inc.
Director Stock Option (Right to Buy)
2022-06-14+15,750→ 15,750 total
Purchase
eFFECTOR Therapeutics, Inc.
Common Stock
2022-06-07$1.37/sh+20,000→ 214,978 total
Award
eFFECTOR Therapeutics, Inc.
Common Stock
2022-05-13$1.53/sh+1,837→ 194,978 total
Award
eFFECTOR Therapeutics, Inc.
Stock Option (Right to Buy)
2022-01-20+520,674→ 520,674 total
Award
eFFECTOR Therapeutics, Inc.
Stock Option (Right to Buy)
2021-08-25+33,799→ 33,799 total
Award
eFFECTOR Therapeutics, Inc.
Common Stock
2021-08-25$10.00/sh+50,000→ 562,339 total
Award
eFFECTOR Therapeutics, Inc.
Stock Option (Right to Buy)
2021-08-25+619,018→ 619,018 total
Award
eFFECTOR Therapeutics, Inc.
Earn-out Right
2021-08-25+75,472→ 75,472 total
Award
eFFECTOR Therapeutics, Inc.
Common Stock
2021-08-25+512,339→ 512,339 total
Award
eFFECTOR Therapeutics, Inc.
Common Stock
2021-08-25+193,141→ 755,480 total
Award
eFFECTOR Therapeutics, Inc.
Stock Option (Right to Buy)
2021-08-25+217,284→ 217,284 total
Award
eFFECTOR Therapeutics, Inc.
Stock Option (Right to Buy)
2021-08-25+144,856→ 144,856 total
Award
eFFECTOR Therapeutics, Inc.
Stock Option (Right to Buy)
2021-08-25+289,712→ 289,712 total
Award
eFFECTOR Therapeutics, Inc.
Earn-out Right
2021-08-25+220,639→ 220,639 total
Award
Tracon Pharmaceuticals, Inc.
Director Stock Option (Right to Buy)
2021-06-10+10,500→ 10,500 total
Award
Tracon Pharmaceuticals, Inc.
Director Stock Option (Right to Buy)
2020-06-10+4,500→ 4,500 total
Award
Tracon Pharmaceuticals, Inc.
Director Stock Option (Right to Buy)
2019-06-13+15,000→ 15,000 total
Award
Tracon Pharmaceuticals, Inc.
Director Stock Option (Right to Buy)
2018-06-13+15,000→ 15,000 total
Award
Tracon Pharmaceuticals, Inc.
Director Stock Option (Right to Buy)
2017-06-15+15,000→ 15,000 total
Award
Tracon Pharmaceuticals, Inc.
Common Stock
2016-06-01+7,500→ 7,500 total
Award
Tracon Pharmaceuticals, Inc.
Director Stock Option ( Right to Buy)
2015-07-23+15,000→ 15,000 total
Award
Tracon Pharmaceuticals, Inc.
Director Stock Option ( Right to Buy)
2015-07-23+6,103→ 6,103 total
Award
Tracon Pharmaceuticals, Inc.
Director Stock Option ( Right to Buy)
2015-02-25+18,897→ 18,897 total
Award
GenMark Diagnostics, Inc.
Common Stock
2013-05-22+14,922→ 14,922 total
Award
GenMark Diagnostics, Inc.
Stock Option (Right to Buy)
2012-06-13+25,000→ 25,000 total
Award
ANADYS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2010-12-13+300,000→ 300,000 total
Award
ANADYS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2009-12-03+165,150→ 165,150 total
Award
ANADYS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2009-08-18+50,000→ 50,000 total
Award
ANADYS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2006-12-08+100,000→ 100,000 total
Sale
ANADYS PHARMACEUTICALS INC
Common Stock
2006-03-16$16.00/sh−4,000→ 58,704 total
Sale
ANADYS PHARMACEUTICALS INC
Common Stock
2006-03-02$14.00/sh−3,000→ 62,704 total
Exercise/Conversion
ANADYS PHARMACEUTICALS INC
Common Stock
2005-05-31$2.95/sh+25,400→ 26,352 total
Exercise/Conversion
ANADYS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2005-05-31+25,400→ 196,078 total
Award
ANADYS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2004-10-01+50,000→ 50,000 total

Companies

Recent Filings

Address

C/O ANADYS PHARMACEUTICALS, INC. 5871 OBERLIN DRIVE, SUITE 200

SAN DIEGO, CA, 92121

View on SEC.gov